Takeda Pharmaceutical TKPHF
NYSE TKPHF
$34.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Takeda Pharmaceutical Co Ltd (TKPHF) Times Interest Earned (2017 - 2026)

Takeda Pharmaceutical (TKPHF) posted quarterly Times Interest Earned of -$3.15 for Q2 2026, down 83.16% year-over-year from -$18.74 in Q2 2025, and down 67.92% quarter-over-quarter from -$1.88 in Q1 2026.

Takeda Pharmaceutical Co Ltd (TKPHF) Times Interest Earned (2017 - 2026) Analysis & Trends

Takeda Pharmaceutical's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$3.15 for Q2 2026.

  • In Q2 2026, Times Interest Earned fell 83.16% year-over-year to -$3.15; the TTM figure through Jun 2026 stood at -$0.76 (up 53.52% YoY), while the FY2026 annual figure was $0.02, down 98.93% from the prior year.
  • Times Interest Earned for Q2 2026 stood at -$3.15, down from -$1.88 in the prior quarter.
  • The five-year high for Times Interest Earned was $7.66 in Q4 2025, with the low at -$3.15 in Q2 2026.
  • The 5-year median for Times Interest Earned is -$1.91 (2026), against an average of -$1.33.
  • The sharpest annual moves came in 2023 and 2025: Times Interest Earned tumbled 386.21% in 2023, then surged 414.74% in 2025.
  • Takeda Pharmaceutical's Times Interest Earned stood at -$1.84 in 2022, then climbed by 2.3% to -$1.8 in 2023, then jumped by 182.69% to $1.49 in 2024, then soared by 414.74% to $7.66 in 2025, then slumped by 141.16% to -$3.15 in 2026.
  • Business Quant data shows TKPHF's Times Interest Earned at -$3.15 in Q2 2026, -$1.88 in Q1 2026, and $7.66 in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.15
Mar 31, 2026 -1.88
Dec 31, 2025 5.07
Sep 30, 2025 -1.35
Jun 30, 2025 -1.72
Mar 31, 2025 1.34
Dec 31, 2024 0.47
Sep 30, 2024 -3.26
Jun 30, 2024 -2.79
Mar 31, 2024 1.41
Dec 31, 2023 -0.51
Sep 30, 2023 -3.79
Jun 30, 2023 -2.83
Mar 31, 2023 1.44
Dec 31, 2022 -1.16
Sep 30, 2022 -0.96
Jun 30, 2022 -2.71
Mar 31, 2022 2.03
Dec 31, 2021 -0.81
Sep 30, 2021 -0.93